Aspergillus

Merck’s New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL® (posaconazole) Receives FDA Priority Review
Yahoo
Mon, 11/18/13 - 09:59 am
Merck
Noxafil
Aspergillus
Candida
FDA